Conference Coverage

'New benchmark' set in phase-3 blood cancer study

Publish date: June 3, 2022

 

FROM ASCO 2022

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

COVID-19: Experts hasten to head off mental health crisis
B-Cell Lymphoma ICYMI
FDA okays new CAR T therapy, first for mantle cell lymphoma
B-Cell Lymphoma ICYMI
Hepatitis screening now for all patients with cancer on therapy
B-Cell Lymphoma ICYMI
Survey quantifies COVID-19’s impact on oncology
B-Cell Lymphoma ICYMI
New inhibitor shows promise in previously failed B-cell malignancies
B-Cell Lymphoma ICYMI
Don’t delay: Cancer patients need both doses of COVID vaccine
B-Cell Lymphoma ICYMI
ZUMA-2, TRANSCEND data pique interest in earlier CAR T for R/R MCL
B-Cell Lymphoma ICYMI
New trials in lymphoma and MM: Could your patient benefit?
B-Cell Lymphoma ICYMI
Ex–hospital porter a neglected giant of cancer research
B-Cell Lymphoma ICYMI
Third-generation Black woman physician makes cancer research history
B-Cell Lymphoma ICYMI